Clinical Trial Update: Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of SHR8028 eye drops for dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• SHR8028 eye drops

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED